Jørgen Falkbøll is Project Director at Novo Nordisk Diabetes API US project. He has been employed by Novo Nordisk for 15 years, with roles as Project Manager and Project Director for a broad range of Capital Investment Projects. Since 2015 he has worked as Director at the Novo Nordisk Diabetes API US project, establishing one of the largest green field pharmaceutical manufacturing facilities in the world. Prior to working at Novo Nordisk, Mr. Falkbøll held various engineering positions as well as a position as Head of Facilities and Engineering at CMC Biologics in Copenhagen. Mr. Falkbøll holds a Bachelor of Engineering from the Engineering College of Copenhagen and a Master Degree in Project Management from the University of Southern Denmark.